OCULAR HYPERTENSION
Clinical trials for OCULAR HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new OCULAR HYPERTENSION trials appear
Sign up with your email to follow new studies for OCULAR HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Revolutionary eye implant could replace daily drops for glaucoma patients
Disease control Recruiting nowThis study tests a tiny implant that releases medication to lower eye pressure in people with glaucoma or high eye pressure who are also having cataract surgery. About 400 participants will receive either the implant during surgery or standard eye drops. The goal is to see if the…
Matched conditions: OCULAR HYPERTENSION
Phase: PHASE3 • Sponsor: SpyGlass Pharma, Inc. • Aim: Disease control
Last updated May 17, 2026 04:13 UTC
-
New laser could ease glaucoma for chinese patients
Disease control Recruiting nowThis study tests a new laser treatment called Direct Selective Laser Trabeculoplasty (DSLT) in 45 Chinese patients with glaucoma or high eye pressure. The goal is to see if it safely lowers eye pressure over 6 to 12 months. Participants must have mild to moderate disease and good…
Matched conditions: OCULAR HYPERTENSION
Phase: NA • Sponsor: BelkinVision • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Laser zaps eye drops: new study aims to cut glaucoma medication burden
Disease control Recruiting nowThis study tests a laser treatment called DSLT in 60 adults with glaucoma or high eye pressure who currently use 1-3 eye drops to keep their eye pressure under control. The goal is to see if the laser can reduce or eliminate the need for daily eye drops while still keeping eye pr…
Matched conditions: OCULAR HYPERTENSION
Sponsor: The Eye Institute of West Florida • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New combo eye drop may offer Round-the-Clock glaucoma relief
Disease control Recruiting nowThis study tests whether a combination eye drop (Rocklatan) lowers eye pressure better over a full day than a standard drop (Latanoprost) in people with open-angle glaucoma or high eye pressure. About 30 adults will use one drop of each medicine in different eyes nightly. The goa…
Matched conditions: OCULAR HYPERTENSION
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New eye drop aims to lower pressure in glaucoma patients
Disease control Recruiting nowThis study tests a new eye drop called HUC3-637 in 206 adults with primary open-angle glaucoma or ocular hypertension. The goal is to see if it safely lowers eye pressure better than an existing treatment. Participants will use the drops for a period and have their eye pressure m…
Matched conditions: OCULAR HYPERTENSION
Phase: PHASE3 • Sponsor: Huons Co., Ltd. • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
New eye injection aims to tame glaucoma pressure
Disease control Recruiting nowThis study tests an experimental eye injection called AGN-193408 SR in people with open-angle glaucoma or high eye pressure. The goal is to see if it safely lowers pressure inside the eye, which can prevent vision loss. About 96 adults who have had cataract surgery at least 4 mon…
Matched conditions: OCULAR HYPERTENSION
Phase: PHASE1, PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated May 11, 2026 20:47 UTC
-
Eye implant could replace daily drops for glaucoma patients having cataract surgery
Disease control Recruiting nowThis study tests a tiny implant that releases medication to lower eye pressure in people with glaucoma or high eye pressure who are also having cataract surgery. About 400 participants will receive either the implant during surgery or standard eye drops. The goal is to see if the…
Matched conditions: OCULAR HYPERTENSION
Phase: PHASE3 • Sponsor: SpyGlass Pharma, Inc. • Aim: Disease control
Last updated May 04, 2026 16:18 UTC
-
AI eye check could catch glaucoma early in underserved communities
Diagnosis Recruiting nowThis study tests whether using an AI tool to screen for glaucoma and other eye conditions at community health centers works better than usual care. About 1,800 adults at higher risk for eye disease will get a quick eye screening. If the AI finds a problem, patients are referred t…
Matched conditions: OCULAR HYPERTENSION
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Diagnosis
Last updated May 17, 2026 04:13 UTC
-
Smart contact lens could revolutionize glaucoma monitoring
Diagnosis Recruiting nowThis study tests a special contact lens that measures eye pressure continuously over 24 hours in people with glaucoma or high eye pressure. The goal is to see if it works as well as the standard method (a quick office test). If successful, it could help doctors better manage glau…
Matched conditions: OCULAR HYPERTENSION
Phase: NA • Sponsor: Sensimed AG • Aim: Diagnosis
Last updated May 13, 2026 15:59 UTC
-
Eye drop alternative injection studied for gentler glaucoma care
Knowledge-focused Recruiting nowThis study looks at whether a slow-release eye injection (Durysta) can reduce eye surface inflammation caused by daily glaucoma eye drops. Researchers will measure a marker of inflammation (caspase-1) in 20 adults with open-angle glaucoma or high eye pressure. The goal is to see …
Matched conditions: OCULAR HYPERTENSION
Phase: PHASE4 • Sponsor: University of Miami • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC